Related Experiment Videos

[Crohn disease, energy expenditure and fat-free mass]

Gastroenterologie Clinique Et Biologique

|January 1, 1993

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab.

Gut·2017

Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease.

Alimentary pharmacology & therapeutics·2016

Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn's Disease: A Prospective Cohort-Study in High-Risk Patients.

Journal of Crohn's & colitis·2016

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Alimentary pharmacology & therapeutics·2015

The outcome of infliximab dose doubling in 157 patients with ulcerative colitis after loss of response to infliximab.

Alimentary pharmacology & therapeutics·2015

Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease.

Journal of Crohn's & colitis·2014

See all related articles